News

Concern over the lack of significant minority participation by patients in clinical trials has waxed and waned over the past 30 years. Now, there is growing momentum in favor if boosting the numbers—and it's about time, because minority patients can no longer wait. ...

Illumina, Inc., which has a Madison affiliate, Epicentre, announced the launch of its new high-density genotyping array, the Infinium™ Global Diversity Array. This new array was developed for and inspired by the All of Us Research Program. All of Us is an historic effort to gather data from one million or more people living in the United States, to accelerate human disease research and improve health. ...

We're, technically, not allowed to enroll badgers, but the "Big Man" was kind enough to help us demonstrate how easy the All of Us enrollment process is....

The underrepresentation of nonwhite ethnic groups in scientific research and in clinical trials is a disturbing trend. The implications of this problem in the limited realm of clinical trials have been reported, but the roots of the disparity run much deeper. Human genomic databases—collections of all the genetic information that has been sequenced over the years—are also heavily skewed toward people of European descent. Research programs, such as All of Us, aim to change this....